The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases

被引：0
|
作者：
Breanne Lechner
Carlo DeAngelis
Noreen Jamal
Urban Emmenegger
Natalie Pulenzas
Angie Giotis
Parker Sheehan
May Tsao
Gillian Bedard
Edward Chow
机构：
[1] University of Toronto,Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[2] University of Toronto,Department of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[3] University of Toronto,Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Denosumab; Hypocalcemia; Bone metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1765 / 1771
页数：6
相关论文
共 50 条
  • [21] Treating asymptomatic bone metastases in patients with lung cancer with denosumab can improve QOL
    Leonard, P. C.
    Wright, P.
    Kantilal, K.
    LUNG CANCER, 2017, 103 : S65 - S66
  • [22] Subjective effects of pamidronate on pain, in patients with symptomatic bone metastases in advanced breast cancer
    Ferrero, G
    Valle, A
    Bertetto, O
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S126 - S126
  • [23] STIMULATION OF CALCIUM REABSORPTION OBSERVED IN ADVANCED BREAST-CANCER PATIENTS WITH HYPERCALCEMIA AND MULTIPLE BONE METASTASES
    KIMURA, S
    ADCHI, I
    YAMAGUCHI, K
    SUZUKI, M
    SHIMADA, A
    SATO, Y
    NAGAOKA, K
    ABE, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (04): : 308 - 314
  • [24] Castration Resistant Prostate Cancer: Denosumab prevents bone metastases
    Kriegeskorte, Volker
    AKTUELLE UROLOGIE, 2011, 42 (05) : 281 - 281
  • [25] Management of bone metastases in refractory prostate cancer - role of denosumab
    Paller, Channing J.
    Carducci, Michael A.
    Philips, George K.
    CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 363 - 371
  • [26] COMPARISON OF DENOSUMAB VERSUS ZOLEDRONIC ACID (ZA) FOR TREATMENT OF BONE METASTASES IN ADVANCED CANCER PATIENTS: AN INTEGRATED ANALYSIS OF 3 PIVOTAL TRIALS
    Lipton, A.
    Siena, S.
    Rader, M.
    Bilynskyy, B.
    Viniegra, M.
    Richardson, G.
    Beuzeboc, P.
    Clemens, M.
    Ke, C.
    Jun, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 380 - 380
  • [27] Bone metabolism biomarkers in men with advanced prostate cancer (PC) and bone metastases treated with denosumab versus zoledronic acid (ZA).
    Smith, Matthew Raymond
    Brown, Janet Elizabeth
    Fizazi, Karim
    Klotz, Laurence
    Marx, Gavin M.
    Wang, Huei
    Warner, Douglas
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [28] Bone turnover markers as predictors of hypocalcemia in patients with bone metastases receiving denosumab
    Tsuchiya, Koki
    Oshita, Yusuke
    Emori, Haruka
    Tani, Soji
    Nagai, Takashi
    Ennis, Austin
    Ishikawa, Mahoko
    Kudo, Yoshifumi
    Alman, Benjamin
    Ishikawa, Koji
    JBMR PLUS, 2025, 9 (04)
  • [29] Usefulness of denosumab to nonsquamous non-small cell lung cancer patients with bone metastases
    Udagawa, Hibiki
    Niho, Seiji
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Ohmatsu, Hironobu
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
    Xie, Jipan
    Diener, Melissa
    Sorg, Rachael
    Wu, Eric Q.
    Namjoshi, Madhav
    CLINICAL BREAST CANCER, 2012, 12 (04) : 247 - 258
12345